You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ECOG score

Showing 1 - 25 of 8,926
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Spinal Cord Injury, Tetraplegia Trial (ARC-BSI Cervical system)

Not yet recruiting
  • Cervical Spinal Cord Injury
  • Tetraplegia
  • ARC-BSI Cervical system
  • (no location specified)
Dec 22, 2022

Insomnia Trial (cognitive behavioral therapy for sleep, anxiety, and depression, education about healthy nutrition habits and

Not yet recruiting
  • Insomnia
  • cognitive behavioral therapy for sleep, anxiety, and depression
  • education about healthy nutrition habits and communication in older age
  • (no location specified)
Sep 4, 2023

Monitor Lung Cancer Patients Activity And Assess Performance

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Actigraphy device (wearable) and mobile application
  • Alcorcon, Madrid, Spain
  • +10 more
Jan 13, 2023

Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)

Not yet recruiting
  • Hypopharyngeal Cancer
  • Cisplatin/Nedaplatin, albumin paclitaxel
  • (no location specified)
May 5, 2023

NSCLC (NSCLC) Trial in New York (Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • New York, New York
    Mount Sinai Hospital
Jan 23, 2023

Small Cell Lung Carcinoma Trial in France (Durvalumab)

Recruiting
  • Small Cell Lung Carcinoma
  • Aix-en-Provence, France
  • +35 more
Jan 16, 2023

NK Cell, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory Trial in Hubei (autologous NK cell)

Not yet recruiting
  • NK Cell
  • +2 more
  • autologous NK cell
  • Hubei, Xiangyang, China
    EC of Xiangyang No.1 People's Hospital Hubei University of Medic
Jun 19, 2023

Fatigue, Locally Advanced or Metastatic Breast Cancer Trial in Germany, Italy, United States (Reparixin, Placebo)

Recruiting
  • Fatigue
  • Locally Advanced or Metastatic Breast Cancer
  • Fort Myers, Florida
  • +23 more
May 17, 2022

Prostate Cancer Patients Treated With 6-month Triptorelin

Not yet recruiting
  • Prostate Cancer
    • (no location specified)
    Mar 6, 2023

    NSCLC Stage IV Trial in Spain (Atezolizumab)

    Completed
    • Non-small Cell Lung Cancer Stage IV
    • Elche, Alicante, Spain
    • +14 more
    Jan 26, 2023

    Post-Acute COVID-19 Syndrome Trial in Farmington (NeuroFlex (computerized gamified tasks))

    Not yet recruiting
    • Post-Acute COVID-19 Syndrome
    • NeuroFlex (computerized gamified tasks)
    • Farmington, Connecticut
      UConn Health
    Jan 28, 2023

    Quality of Life in Patients Undergone Vulvar Reconstruction

    Recruiting
    • Vulvar Neoplasms
    • Quality of life questionnaires
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Nov 13, 2023

    Usability of Cellworks Singula™ and Cellworks Ventura™ Reports

    Recruiting
    • Cancer
    • +2 more
    • Cellworks Report
    • Sioux Falls, South Dakota
      Avera Cancer Institute
    Jan 20, 2023

    Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

    Completed
    Has Results
    • Breast Neoplasms
    • KU-0059436 (AZD2281) (PARP inhibitor)
    • West Hollywood, California
    • +16 more
    Jan 24, 2023

    Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

    Recruiting
    • Adenocarcinoma of Stomach
    • Gentuximab Injection
    • Gentuximab Injection Placebo
    • Shanghai, Shanghai, China
      Shanghai Dongfang Hospital
    Jun 16, 2023

    CARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients

    Recruiting
    • Nivolumab Related Toxicity
    • there is no intervention
    • Tekirdağ, Turkey
      Tekirdağ Namık Kemal University
    Oct 2, 2022

    Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

    Not yet recruiting
    • Granulocyte Colony-Stimulating Factor
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 31, 2023

    High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1

    Suspended
    • NSCLC Stage IV
    • NSCLC, Stage IIIC
    • Primary Immune Response (PIR) test by Biodesix, Inc.
    • San Carlos, California
    • +1 more
    Jan 26, 2023

    Chemotherapy Toxicity and Survival in Elderly Cancer CARG Score

    Not yet recruiting
    • Solid Tumors ,Adults
    • calculating CARG score
    • (no location specified)
    Jul 18, 2022

    Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)

    Active, not recruiting
    • Small Cell Carcinoma, Hypercalcaemic Type
    • Ovarian Cancer
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in

    Recruiting
    • DCIS
      • Victoria, British Columbia, Canada
      • +9 more
      Jan 31, 2023

      A Registry for Patients With Systemic Mastocytosis in China

      Not yet recruiting
      • Systemic Mastocytoses
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Aug 24, 2023

        Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)

        Active, not recruiting
        • Elderly Metastatic Colorectal Cancer Patients
        • Padua, Italy
          Istituto Oncologico Veneto IRCCS
        Mar 30, 2022

        Multiple Myeloma Trial in Nantong (Colchicine, Lenalidomide)

        Recruiting
        • Multiple Myeloma
        • Nantong, Jiangsu, China
          Affiliated Hospital of Nantong University
        Mar 25, 2023

        Platinum-resistant Recurrent Ovarian Cancer Trial in Wuhan (Docetaxel for injection (Albumin-bound), Bevacizumab)

        Recruiting
        • Platinum-resistant Recurrent Ovarian Cancer
        • Wuhan, Hubei, China
          Tongji Hospital,Tongji Medical College of HUST
        Oct 12, 2022